Literature DB >> 8583748

[Ocular tuberculosis in systemic lupus erythematosus and immunosuppressive therapy].

N Anders1, G Wollensak.   

Abstract

BACKGROUND: A marked reduction in eye disease attributed to tuberculosis has occurred over the past several decades. In recent years, however, tuberculosis has reemerged as a serious public health problem. We report a case of a severe ocular tuberculosis in a patient with systemic lupus erythematosus and immunosuppressive therapy. PATIENT: The 36-years-old woman underwent an immunosuppressive therapy because of a systemic lupus erythematosus detected two years earlier. After holidays on the Philippines Mycobacterium tuberculosis was found in a bronchial lavage. Two months later fundoscopy showed severe subretinal exsudation with overlying serous retinal detachment. Within several months these findings progressed to a panuveitis with spontaneous perforation. Histopathologically a granulomatous panophthalmitis could be found with giant cells. Two months later acid-fast bacilli were detected in orbital lesions.
CONCLUSION: In immunosuppressed patients there is still an increased risk for severe ocular tuberculosis. Therefore it is important to think of this almost forgotten disease in those cases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8583748     DOI: 10.1055/s-2008-1035391

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

Review 1.  Ocular Tuberculosis.

Authors:  Daniel M Albert; Meisha L Raven
Journal:  Microbiol Spectr       Date:  2016-11

2.  Endogenous Tuberculous Endophthalmitis and Panophthalmitis: A Systematic Review of Case Reports and Case Series.

Authors:  Fares Antaki; Simon Javidi; Samir Touma; Marie-Josée Aubin
Journal:  Clin Ophthalmol       Date:  2020-10-07

3.  Tuberculous Panophthalmitis with Lymphadenitis and Central Nervous System Tuberculoma.

Authors:  Sirawat Srichatrapimuk; Duangkamon Wattanatranon; Somnuek Sungkanuparph
Journal:  Case Rep Infect Dis       Date:  2016-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.